2016
DOI: 10.1016/j.dld.2016.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 1 publication
0
8
0
Order By: Relevance
“…Complementary therapy, such as adjuvant systemic chemotherapy, shows no benefit in overall survival and is not recommended for the treatment of such lesions 12 . Only two cases were identified where surgery was not preferred as the first‐line treatment, but the clinical course of the disease was worse than in cases that underwent surgery 55,56 . Bolzacchini et al .…”
Section: Discussionmentioning
confidence: 99%
“…Complementary therapy, such as adjuvant systemic chemotherapy, shows no benefit in overall survival and is not recommended for the treatment of such lesions 12 . Only two cases were identified where surgery was not preferred as the first‐line treatment, but the clinical course of the disease was worse than in cases that underwent surgery 55,56 . Bolzacchini et al .…”
Section: Discussionmentioning
confidence: 99%
“…Metastatic gastric melanoma are more common than primary ones; PGM are rare in clinic, and the related literature is also relatively scarce[2-5]. Imaging examination is of great value in melanoma diagnosis and reexamination.…”
Section: Discussionmentioning
confidence: 99%
“…To date, only three cases have applied CT or MRI examination (Table 1). Bolzacchini et al[2] reported a case in which CT and MRI revealed a thickened stomach wall in the lesser curvature of the stomach, and metastasis to the liver and regional lymph nodes. Wang et al[11] reported a case of primary advanced esophagogastric melanoma.…”
Section: Discussionmentioning
confidence: 99%
“…30% to 40% of these cases presented as detectable masses [10] or symptoms including abdominal pain, weight loss, melena, anemia, and axillary lymphadenopathy [2]. Metastasis to the liver as well as regional lymph nodes from primary gastric melanoma is common [11]. Our patient presented entirely asymptomatically.…”
Section: Discussionmentioning
confidence: 99%
“…At this time, treatment was changed to ipilimumab secondary to tumor progression. Four doses of ipilimumab were administered until the patient passed away 11 months after tumor discovery [11]. This patient's survival was significantly longer than the 5 month median survival time expected for primary gastric melanoma and is an accomplishment when the extensive disease at discovery is considered.…”
Section: Discussionmentioning
confidence: 99%